NTU has developed a new method for synthesizing anti-inflammatory drugs
Naproxen, diclofenac, ibuprofen and other anti-inflammatory drugs are among the most widely used types of drugs in the world. The traditional synthetic methods for these drugs are complicated, expensive and pollute the environment. A few days ago, the research team of Professor Mao Jianyou at the School of Chemistry and Molecular Engineering of Nanjing University of Technology pioneered a new method that used organic photosensitizers and nickel catalysts to synergistically catalyze different halogenated compounds to form anti-inflammatory drug precursors (that is, the basis for the synthesis of a certain drug). Raw materials). The reaction is easy to operate and low in cost, and provides a convenient and effective synthesis method for the innovative synthesis of anti-inflammatory drugs. The research results were published recently in "German Applied Chemistry".
"Compared with the traditional synthesis method, this method has simple and easily available raw materials, simple operation, simple synthetic route, and low reaction cost, which provides a possible development path for subsequent industrial production applications." Professor Mao Jianyou introduced that in the traditional method Organometallic reagents (format reagents, organozinc reagents, organosilicon reagents, organoboron reagents, etc.) will be used. Among them, the format reagent and the organic zinc reagent are very sensitive to air and water, and are flammable and explosive reagents. In the process of use, a little carelessness will cause fire and explosion. Therefore, the requirements for operation during their use are extremely high; ; And the use of reducing metals (zinc powder, manganese powder, magnesium scraps, etc.) will not only cause wear on the experimental instrument, thereby shortening the service life of the instrument, but also cause repeated experiments due to different objective factors such as batch and origin. In addition, the generation of metal salt waste will also pollute the environment.
"Our research team used an organic photosensitizer and a nickel catalyst to synergistically catalyze the reaction of two different halides (iodide and chloride) to produce an anti-inflammatory drug precursor." The first author of the paper, a doctoral student at Nanjing University Guan Haixing stated that this reaction not only avoids the use of organometallic reagents (halogens replace the use of organometallic reagents), but also avoids the use of reducing metals (photosensitizers replace the use of reducing metals); at the same time The organic photosensitizer and alkali used in the reaction can also be recycled repeatedly, which also greatly reduces the reaction cost and provides potential for further industrialization.
Professor Mao Jianyou introduced that halogenated compounds are easy to obtain and are one of the most important raw materials in the field of organic synthesis. In the next step, they will continue to work on synergistic catalytic strategies using photosensitizers and nickel catalysts, select different halogenated compounds for reaction, and thus develop new methods for synthesizing chiral drug precursors, which will be applied to more valuable framework structures ( In the synthesis of the precursor of a drug).
Looking for chemical products? Let suppliers reach out to you!
2026-06-30
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
In 2021, India's Ibuprofen API Export Volume and Price will Fall
-
The First! Blockbuster Anti-inflammatory Drugs Gain New Indications
-
Is it necessary to tighten the import of coal?
-
The GLP-1 Sweet Shot in India’s Diabetic Gut
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Small Pharma Firms Under Threat as Regulator Tightens Quality Norms
-
Sun Pharma’s Utreglutide Shows Promising Weight Loss and Liver Fat Reduction
-
Biocon Weighs Merger of Biocon Biologics to Unlock Value
-
Betting on Next-Generation Metabolic Therapies: Pfizer’s Big Wager on Metsera and Its Strategic Reshaping in China
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
Recommend Reading
-
4 Pharma Firms Lose Licenses in Jammu and Kashmir Amid Illegal Drug Sales Crackdown
-
AstraZeneca Rare Disease Drug Misses Phase 3 Target Hope Shifts to Subgroup Data
-
Over 22,000 New Cases in India AstraZeneca Gets CDSCO Green Light for Muscle-Invasive Bladder Cancer Drug
-
Emcure Seals Exclusive Deal for Sanofi’s Oral Diabetes Brands Millions of Indian Patients to Benefit
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
EU Clears Carlyle's Acquisition of BASF's Coatings Business, but Demands Divestment of Nouryon's Polysulfide Assets: What Are the Underlying Risks?
-
This Week's Propylene Oxide Market Prices First Declined Then Rose (6.1-6.4) in China
-
BDO Market Trends Show Slowing Down
-
Ethylene Oxide Prices Drop Sharply in Early June
-
Ammonium Sulfate Tends to Stabilize After Continuing Its Decline (June 1–June 5)